CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 7. Introduction of Gab1 into 10W2T restores the EGF-dependent association of SHP-2 with EGFR. 10W2T-Gab1 (clone 1; A) or 10W2T-none (clone 7; B) cells were treated with or without 100 ng/ml EGF at 37°C for 1 min. Cells were lysed, and the immunoprecipitation (IP) was performed with specific antibodies for EGFR (Lanes 3 and 4), Gab1 (Lanes 5 and 6), or SHP-2 (Lanes 7 and 8) or with NRS as controls (Lanes 1 and 2). Samples were analyzed by SDS-PAGE and immunoblotting with anti-p-Tyr antibody, followed by ECL. Tyrosine-phosphorylated Gab1 of approximately Mr 110,000 was detected in 10W2T-Gab1 as well as associated with EGFR (A, Lane 6). Tyrosine-phosphorylated proteins of Mr 90,000–100,000 were found to be associated with SHP-2 in EGF-dependent (Mr 90,000) and EGF-independent (Mr 100,000) manners in both 10W2T-Gab1 (A, Lanes 5 and 6) and 10W2T-none (B, Lanes 5 and 6). However, the coprecipitation of tyrosine-phosphorylated EGFR (Mr 170,000) with SHP-2 on EGF stimulation was exclusively observed in 10W2T-Gab1 (A, Lane 8) and not in 10W2T-none (B, Lane 8). The data shown are representative of three independent experiments.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation